CAS: 603139-19-1 - Pentanamide,N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]ethyl]amino]-,(2S)-
Formula:C25H27F4N3O3S
InChI:InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1
InChI key:InChIKey=FWIVDMJALNEADT-SFTDATJTSA-N
SMILES:N#CC1(NC(=O)C(NC(C2=CC=C(C=C2)C=3C=CC(=CC3)S(=O)(=O)C)C(F)(F)F)CC(F)(C)C)CC1
- Synonyms:
- (2S)-N-(1-Cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]ethyl]amino]pentanamide
- N<sup>1</sup>-[(1-Cyanocyclopropyl)-4-fluoro-N<sup>2</sup>-[(1S)-2,2,2-trifluoro-1-[4-methylsulfonyl]-1,1′-biphenyl-4-yl] ethyl]-<span class="text-smallcaps">L</span>-leucinamide
- Odanacatib
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Odanacatib REF: AN-AG0039T3CAS: 603139-19-1 | 98% | To inquire | Wed 08 May 24 | |
Odanacatib REF: TM-T6035CAS: 603139-19-1 | 98.53% | 49.00 €~593.00 € | Wed 15 May 24 | |
MK-0822 REF: TR-M425015CAS: 603139-19-1 | - - - | 231.00 €~1,253.00 € | Tue 21 May 24 | |
MK 0822 REF: 3D-FM65088CAS: 603139-19-1 | Min. 95% | 150.00 €~445.00 € | Tue 21 May 24 |
Odanacatib
Ref: AN-AG0039T3
1mg | To inquire | |
2mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Odanacatib
Ref: TM-T6035
1mg | 49.00 € | |
2mg | 69.00 € | |
5mg | 103.00 € | |
10mg | 165.00 € | |
25mg | 267.00 € | |
50mg | 401.00 € | |
100mg | 593.00 € | |
1ml*10 (DMSO) | 117.00 € |
MK-0822
Controlled ProductRef: TR-M425015
10mg | 231.00 € | |
50mg | 796.00 € | |
100mg | 1,253.00 € |
MK 0822
Ref: 3D-FM65088
10mg | 150.00 € | |
50mg | 445.00 € |